Trial intelligence / Profile preview

Soft Tissue Augmentation with SCTG and PRF for Immediate Implants

NCT03413553Completed

Start
Mar 2018
Primary completion
Sep 2019
Modality
Device-based Delivery
Countries
1
01

Overview

Randomised, single-blind trial of platelet rich fibrin in tooth loss (2 arms). Primary endpoint: Pink Esthetic Score at 6 months. Started Mar 2018; status: completed.

02

Drugs

platelet rich fibrin
03

Conditions

tooth loss

Beyond the preview

Go deeper on NCT03413553.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03413553.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call